Federal Research Institute Of Pediatric Hematology, Oncology And Immunology

This study is testing a combination treatment for children with high-risk neuroblastoma that has not responded to or has come back after initial therapy. It combines standard chemotherapy and immunotherapy drugs with an infusion of the patient's own specially grown immune cells, …

This study aims to find the best way to treat a specific type of leukemia (AML) in children who also have Down syndrome. It will test a standardized, four-part chemotherapy plan across multiple hospitals in Russia. The goal is to help these children live longer, healthier lives b…

This study is testing a new therapy for children and young adults with acute leukemia that has not responded well to standard chemotherapy. The treatment involves giving patients special immune cells, called NK cells, from a donor before and after a stem cell transplant. The main…

This study is testing a new method for stem cell transplants in children with high-risk or relapsed leukemia. The goal is to prevent Graft-Versus-Host Disease (GVHD), a serious complication where donor immune cells attack the patient's body. Researchers are engineering the transp…